Global Throat Cancer Therapeutics Market 2019-2023
SKU ID : TNV-14357694 | Publishing Date : 27-May-2019 | No. of pages : 125
Detailed TOC of Global Throat Cancer Therapeutics Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
2.1 Preface
2.2 Preface
2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
Market ecosystem
Market characteristics
Market segmentation analysis
PART 04: MARKET SIZING
Market definition
Market sizing 2018
Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
Market segmentation by type
Comparison by type
Pharyngeal cancer - Market size and forecast 2018-2023
Laryngeal cancer - Market size and forecast 2018-2023
Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2018-2023
Europe - Market size and forecast 2018-2023
Asia - Market size and forecast 2018-2023
ROW - Market size and forecast 2018-2023
Key leading countries
Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
Market drivers
Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
Overview
Landscape disruption
Competitive scenario
PART 14: VENDOR ANALYSIS
Vendors covered
Vendor classification
Market positioning of vendors
Bristol-Myers Squibb Co.
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Sanofi
PART 15: APPENDIX
Research methodology
List of abbreviations
Definition of market positioning of vendors
PART 16: EXPLORE TECHNAVIO
Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Global throat cancer therapeutics market pipeline: Overview
Exhibit 18: Global throat cancer therapeutics market pipeline: Snapshot
Exhibit 19: Type - Market share 2018-2023 (%)
Exhibit 20: Comparison by type
Exhibit 21: Pharyngeal cancer - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Pharyngeal cancer - Year-over-year growth 2019-2023 (%)
Exhibit 23: Laryngeal cancer - Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Laryngeal cancer - Year-over-year growth 2019-2023 (%)
Exhibit 25: Market opportunity by type
Exhibit 26: Customer landscape
Exhibit 27: Market share by geography 2018-2023 (%)
Exhibit 28: Geographic comparison
Exhibit 29: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: North America - Year-over-year growth 2019-2023 (%)
Exhibit 31: Top 3 countries in North America
Exhibit 32: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 33: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 34: Top 3 countries in Europe
Exhibit 35: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 36: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 37: Top 3 countries in Asia
Exhibit 38: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 40: Top 3 countries in ROW
Exhibit 41: Key leading countries
Exhibit 42: Market opportunity
Exhibit 43: Impact of drivers and challenges
Exhibit 44: Vendor landscape
Exhibit 45: Landscape disruption
Exhibit 46: Vendors covered
Exhibit 47: Vendor classification
Exhibit 48: Market positioning of vendors
Exhibit 49: Bristol-Myers Squibb Co. - Vendor overview
Exhibit 50: Bristol-Myers Squibb Co. - Business segments
Exhibit 51: Bristol-Myers Squibb Co. - Organizational developments
Exhibit 52: Bristol-Myers Squibb Co. - Geographic focus
Exhibit 53: Bristol-Myers Squibb Co. - Key offerings
Exhibit 54: Bristol-Myers Squibb Co. - Key customers
Exhibit 55: Eli Lilly and Co. - Vendor overview
Exhibit 56: Eli Lilly and Co. - Business segments
Exhibit 57: Eli Lilly and Co. - Organizational developments
Exhibit 58: Eli Lilly and Co. - Geographic focus
Exhibit 59: Eli Lilly and Co. - Segment focus
Exhibit 60: Eli Lilly and Co. - Key offerings
Exhibit 61: Eli Lilly and Co. - Key customers
Exhibit 62: F. Hoffmann-La Roche Ltd. - Vendor overview
Exhibit 63: F. Hoffmann-La Roche Ltd. - Business segments
Exhibit 64: F. Hoffmann-La Roche Ltd. - Organizational developments
Exhibit 65: F. Hoffmann-La Roche Ltd. - Geographic focus
Exhibit 66: F. Hoffmann-La Roche Ltd. - Segment focus
Exhibit 67: F. Hoffmann-La Roche Ltd. - Key offerings
Exhibit 68: F. Hoffmann-La Roche Ltd. - Key customers
Exhibit 69: Merck & Co. Inc. - Vendor overview
Exhibit 70: Merck & Co. Inc. - Business segments
Exhibit 71: Merck & Co. Inc. - Organizational developments
Exhibit 72: Merck & Co. Inc. - Geographic focus
Exhibit 73: Merck & Co. Inc. - Segment focus
Exhibit 74: Merck & Co. Inc. - Key offerings
Exhibit 75: Merck & Co. Inc. - Key customers
Exhibit 76: Sanofi - Vendor overview
Exhibit 77: Sanofi - Business segments
Exhibit 78: Sanofi - Organizational developments
Exhibit 79: Sanofi - Geographic focus
Exhibit 80: Sanofi - Segment focus
Exhibit 81: Sanofi - Key offerings
Exhibit 82: Sanofi - Key customers
Exhibit 83: Validation techniques employed for market sizing
Exhibit 84: Definition of market positioning of vendors
Keyplayers in Global Throat Cancer Therapeutics Market 2019-2023
Bristol-Myers Squibb Co.Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Merck & Co., Inc.
Sanofi